User profiles for Charlotte Russell
Charlotte RussellDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's … Verified email at kcl.ac.uk Cited by 2498 |
[HTML][HTML] Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
…, R Davis, N Losic, J Wilms, CA Russell… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose New treatments are needed for patients with fludarabine-and alemtuzumab-refractory
(FA-ref) chronic lymphocytic leukemia (CLL) or patients with fludarabine-refractory CLL …
(FA-ref) chronic lymphocytic leukemia (CLL) or patients with fludarabine-refractory CLL …
Changing faces: A detection advantage in the flicker paradigm
Observers seem surprisingly poor at detecting changes in images following a large transient
or flicker. In this study, we compared this change blindness phenomenon between human …
or flicker. In this study, we compared this change blindness phenomenon between human …
δ-AMINOLEVULINIC ACID, ITS ROLE IN THE BIOSYNTHESIS OF PORPHYRINS AND PURINES1
D Shemin, CS Russell - Journal of the American Chemical Society, 1953 - ACS Publications
Sirs: We wish to report our finding that-aminolevu-linic acid (II) can replace the two
substrates,“active” succinate2· 3'4 and glycine6, 6 for porphyrin syn-thesis. It would appear …
substrates,“active” succinate2· 3'4 and glycine6, 6 for porphyrin syn-thesis. It would appear …
The role of perceptual load in processing distractor faces
It has been established that successful ignoring of irrelevant distractors depends on the
extent to which the current task loads attention. However, the previous load studies have …
extent to which the current task loads attention. However, the previous load studies have …
Segmentation, attention and phenomenal visual objects
Issues concerning selective attention provoke new questions about visual segmentation, and
vice-versa. We illustrate this by describing our recent work on grouping under conditions of …
vice-versa. We illustrate this by describing our recent work on grouping under conditions of …
Inattentional blindness versus inattentional amnesia for fixated but ignored words
People often are unable to report the content of ignored information, but it is unknown whether
this reflects a complete failure to perceive it (inattentional blindness) or merely that it is …
this reflects a complete failure to perceive it (inattentional blindness) or merely that it is …
Contrast polarity and face recognition in the human fusiform gyrus
Functional imaging has revealed face-responsive visual areas in the human fusiform gyrus,
but their role in recognizing familiar individuals remains controversial. Face recognition is …
but their role in recognizing familiar individuals remains controversial. Face recognition is …
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants
…, N Milpied, L Volin, CA Russell… - Blood, The Journal …, 2002 - ashpublications.org
Oral valacyclovir for cytomegalovirus (CMV) prophylaxis in bone marrow transplantation (BMT)
was investigated in a randomized, double-blind, acyclovir-controlled, multicenter clinical …
was investigated in a randomized, double-blind, acyclovir-controlled, multicenter clinical …
Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging
MO Longas, CS Russell, XY He - Carbohydrate research, 1987 - Elsevier
Three dermatan sulfates (DS 18 , DS 28 , and DS 35 ) were isolated from women's skin of
ages 19 ±2.5, 35 ±3.5, 47 ±1.7, 60 ±0.8, and 75 ±5 years. They sequentially precipitated with …
ages 19 ±2.5, 35 ±3.5, 47 ±1.7, 60 ±0.8, and 75 ±5 years. They sequentially precipitated with …
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study
…, TS Lin, S Lisby, M Schultz, CA Russell… - Blood, The Journal …, 2012 - ashpublications.org
New treatments are required for rituximab-refractory follicular lymphoma (FL). In the present
study, patients with rituximab-refractory FL received 8 weekly infusions of ofatumumab (…
study, patients with rituximab-refractory FL received 8 weekly infusions of ofatumumab (…